Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study

Blood

Volumn 94, Issue 7, 1999, Pages 2208-2216

  Curtis, Rochelle E ^a   Travis, Lois B ^b   Rowlings, Philip A ^b   Socié, Gérard ^b   Kingma, Douglas W ^b   Banks, Peter M ^b   Jaffe, Elaine S ^b   Sale, George E ^b   Horowitz, Mary M ^b   Witherspoon, Robert P ^b   Shriner, Donna A ^b   Weisdorf, Daniel J ^b   Kolb, Hans Jochem ^b   Sullivan, Keith M ^b   Sobocinski, Kathleen A ^b   Gale, Robert Peter ^b   Hoover, Robert N ^b   Fraumeni Jr , Joseph F ^b   Deeg, H Joachim ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY CD3; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELLULAR IMMUNITY; CHILD; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOREGULATION; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISORDERS; MALE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES;

EID: 0033214901     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Deeg HJ, Socié G: Malignancies after hematopoietic stem cell transplantation: Many questions, some answers. Blood 91:1833, 1998
2. Bhatia S, Ramsay NK, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, Robison LL, Miller JS, Neglia JP: Malignant neoplasms following bone marrow transplantation. Blood 87:3633, 1996
3. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, Thomas D, Storb R, Thomas ED: Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 321:784, 1989
4. O'Reilly RJ, Lacerda JF, Lucas KG, Rosenfield NS, Small TN, Papadopoulos EB: Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants, in De Vita TD, Helman S, Rosenberg SA (eds): Important Advances in Oncology 1996. Philadelphia, PA, Lippincott-Raven, 1996, p 149
5. Orazi A, Hromas RA, Neiman RS, Greiner TC, Lee CH, Rubin L, Haskins S, Heerema NA, Gharpure V, Abonour R, Srour EF, Cornetta K: Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. Am J Clin Pathol 107:419, 1997
6. Lustig JP, Lugassy G, Neder A, Sigler E: Head and neck carcinoma in Fanconi's anaemia - Report of a case and review of the literature. Eur J Cancer B Oral Oncol 31B:68, 1995
7. Filipovich AH, Mathur A, Kamat D, Shapiro RS: Primary immunodeficiencies: Genetic risk factors for lymphoma. Cancer Res 52:5465s, 1992 (suppl 19)
8. Martin PJ, Shulman HM, Schubach WH, Hansen JA, Fefer A, Miller G, Thomas ED: Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. Ann Intern Med 101:310, 1984
9. Knowles DM, Cesarman E, Chadbum A, Frizzera G, Chen J, Rose EA, Michler RE: Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552, 1995
10. d'Amore ESG, Manivel JC, Gajl-Peczalska KJ, Litz CE, Copenhaveeeer CM, Shapiro RS, Stricker JG: B-cell lymphoproliferative disorders after bone marrow transplant. An analysis of ten cases with emphasis on Epstein-Barr virus detection by in situ hybridization. Cancer 68:1285, 1991
11. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM: Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood 72:520, 1988
12. Zutter MM, Durnam DM, Hackman RC, Loughran TP Jr, Kidd PG, Ashley RL, Petersdorf EW, Martin PJ, Thomas ED: Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol 94:714, 1990
13. Trimble MS, Waye JS, Walker IR, Brain MC, Leber FB: B-cell lymphoma of recipient origin 9 years after allogeneic bone marrow transplantation for T-cell acute lymphoblastic leukaemia. Br J Haematol 85:99, 1993
14. Brion A, Calm JY, Mougin C, Angonin R, Flesch M, Deschaseaux ML, Plouvier E, Deconinck E, Voillat L, Racadot E, Carbillet JP, Herve P: Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: Clinical and biological characteristics of six cases. Nouv Rev Fr Hematol 37:289, 1995
15. Verschuur A, Brousse N, Raynal B, Brison O, Rohrlich P, Rahimy C, Vilmer E: Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transplant 14:467, 1994
16. Kingma DW, Medeiros LJ, Barletta J, Raffeld M, Mann RB, Ambinder RF, Jaffe ES: Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease. Am J Surg Pathol 18:48, 1994
17. Breslow NE, Day NE: Statistical Methods in Cancer Research. Vol II - The Design and Analysis of Cohort Studies. Lyon, France, International Agency for Research on Cancer, 1987 (IARC scientific publication no. 82)
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
19. Preston DL, Lubin JH, Pierce DA: Epicure User's Guide. Seattle, WA, HiroSoft Intl Corp, 1993
20. Cox DR: Regression models and life-tables (with discussions). J R Stat Soc B 34:187, 1972
21. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socié G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Schoch HG, Sale GE, Storb R, Travis WD, Kolb HJ, Gale RP, Passweg JR, Boice JD Jr: Solid cancers after bone marrow transplantation. N Engl J Med 336:897, 1997
22. Goedert JJ, Cote TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ: Spectrum of AIDS-associated malignant disorders. Lancet 351:1833, 1998
23. Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR Jr: Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 62:370, 1996
24. Opelz G, Henderson R: Incidence of non-Hodgkin's lymphoma in kidney and heart transplant recipients. Lancet 342:1514, 1993
25. Hoover RN: Lymphoma risks in populations with altered immunity - A search for mechanism. Cancer Res 52:5477s, 1992 (suppl 19)
26. Kinlen LJ: Immunologic factors, including AIDS, in Schottenfeld D, Fraumeni JF Jr (eds): Cancer Epidemiology and Prevention (ed 2). New York, NY, Oxford University Press, 1996, p 532
27. Cohen JI: Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore) 70:137, 1991
28. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifarre R, Fisher RI: Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 323:1723, 1990
29. Liebowitz D: Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 338:1413, 1998
30. Nalesnik MA, Makowka L, Starzl TE: The diagnosis and treatment of posttransplant lymphoproliferative disorders. Curr Probl Surg 25:367, 1988
31. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, Mckenna RW, Sibley RK, Holahan KP, Lindquist LL: Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262, 1981
32. Shapiro RS, McClain K, Frizzera G, Gajl-Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B, Ramsay NKC, McGlave P, Filipovich AH: Epstein-Barr virus associated B cell lymphproliferative disorders following bone marrow transplantation. Blood 71:1234, 1988
33. Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emanuel DJ: Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91:3654, 1998
34. Rooney CM, Smith CA, Ng CY, Loftin SK, Sixbey JW, Gan Y, Srivastava DK, Bowman LC, Krance RA, Brenner MK, Heslop HE: Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92:1549, 1998
35. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kernan NA, O'Reilly RJ: Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 330:1185, 1994
36. Bhatia S, Krishnan A, Niland J, Forman S: Second malignant neoplasms (SMN) following bone marrow transplantation (BMT) for hematologic malignancies: City of Hope experience. Blood 90:378a, 1997 (suppl 1, abstr)
37. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ: The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood 87:2594, 1996
38. Roux E, Helg C, Dumont-Girard F, Chapuis B, Jeannet M, Roosnek E: Analysis of T-cell repopulation after allogeneic bone marrow transplantation: Significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 87:3984, 1996
39. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ: Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 73:1340, 1989
40. Davey DD, Kamat D, Laszewski M, Goeken JA, Kemp JD, Trigg ME, Purtilo DT, Davis J, Dick FR: Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: An immunologic and genotypic analysis. Mod Pathol 2:27, 1989
41. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JLM: Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood 90:3204, 1997
42. Meignin V, Devergie A, Brice P, Brison O, Parquet N, Ribaud P, Cojean I, Gaulard P, Gluckman E, Socié G, Janin A: Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogenous chronic leukemia. Transplantation 65:595, 1998
43. Schouten HC, Hopman AH, Haesevoets AM, Arends JW: Large-cell anaplastic non-Hodgkin's lymphoma originating in donor cells after allogeneic bone marrow transplantation. Br J Haematol 91:162, 1995
44. O'Riordan JM, Molloy K, O'Briain DS, Corbally N, Devaney D, McShane D, Considine N, McCann SR: Localized, late-onset, high-grade lymphoma following bone marrow transplantation: Response to combination chemotherapy. Br J Haematol 86:183, 1994
45. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS: Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10: 877, 1991
46. Antin JH, Bierer BE, Smith BR, Ferrara J, Guinan EC, Sieff C, Golan DE, Macklis RM, Tarbell NJ, Lynch E, Reichert TA, Blythman H, Bouloux C, Rappeport JM, Burakoff SJ, Weinstein HJ: Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: Effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies. Blood 78:2139, 1991
47. Gerritsen EJ, Stam ED, Hermans J, van den Berg H, Haraldsson A, van Tol MJD, van den Bergh RL, Waaijer JLM, Kroes ACM, Kluin PM, Vossen JM: Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children. Bone Marrow Transplant 18:377, 1996
48. Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A: Bone marrow transplantation from genetically HLA-nonidemical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: Use of two monoclonal antibodies to prevent graft rejection. Pediatrics 98:420, 1996
49. Hale G, Waldmann H: Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users. Blood 91:3079, 1998
50. Flinn I, Orentas R, Noga SJ, Marcellus D, Vogelsang GB, Jones RJ, Ambinder RF: Low risk of Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) in patients receiving elutriated allogeneic marrow transplants may reflect depletion of EBV infected lymphocytes from the graft. Blood 86:626a 1995 (suppl 1, abstr)
51. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM: Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396, 1995
52. Leblond V, Davi F, Charlotte F, Dorent R, Bitker MO, Sutton L, Gandjbakhch I, Binet JL, Raphael M: Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16:2052, 1998
53. Riddler SA, Breinig MC, McKnight JL: Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972, 1994
54. Savoie A, Perpête C, Carpentier L, Joncas J, Alfieri C: Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood 83:2715, 1994
55. Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Keslop HE: Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345:9, 1995
56. Benkerrou M, Jais JP, Leblond V, Durandy A, Sutton L, Bordigoni P, Garnier JL, Le Bidois J, Le Deist F, Blanche S, Fischer A: Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: Prognostic factors and long-term outcome. Blood 92:3137, 1998